PTO- 1478 |
Approved for use through 08/31/2021. OMB 0651-0009 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Serial Number: 90895336 |
Filing Date: 08/21/2021 |
Input Field |
Entered |
SERIAL NUMBER | 90895336 |
---|---|
MARK INFORMATION | |
*MARK | \\TICRS\EXPORT18\IMAGEOUT 18\908\953\90895336\xml1 \ APP0002.JPG |
SPECIAL FORM | YES |
USPTO-GENERATED IMAGE | NO |
LITERAL ELEMENT | 2seventybio |
COLOR MARK | YES |
COLOR(S) CLAIMED (If applicable) |
The color(s) light green and dark green is/are claimed as a feature of the mark. |
*DESCRIPTION OF THE MARK (and Color Location, if applicable) |
The mark consists of the stylized design of a 7 comprised of an elongated upper triangle in dark green and an elongated lower triangle in light green, with the stylized design of the 7 to left of "2SEVENTYBIO" in stylized lowercase letters. The elongated upper triangle has a rounded point at its upper right, and its lower side is curved inwardly where it interfaces with the lower elongated triangle, which has a rounded point at its upper right. "2SEVENTY" is bolded relative to "BIO". |
PIXEL COUNT ACCEPTABLE | YES |
PIXEL COUNT | 547 x 264 |
REGISTER | Principal |
APPLICANT INFORMATION | |
*OWNER OF MARK | 2seventy bio, Inc. |
*MAILING ADDRESS | 60 Binney Street |
*CITY | Cambridge |
*STATE (Required for U.S. applicants) |
Massachusetts |
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | United States |
*ZIP/POSTAL CODE (Required for U.S. and certain international addresses) |
02142 |
*EMAIL ADDRESS | XXXX |
LEGAL ENTITY INFORMATION | |
TYPE | corporation |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION | Delaware |
GOODS AND/OR SERVICES AND BASIS INFORMATION | |
INTERNATIONAL CLASS | 005 |
*IDENTIFICATION | Pharmaceutical preparations and substances for the treatment of diseases, namely genetic diseases, diseases of the immune system, infectious diseases, autoimmune diseases, and cancer; genetically modified cells, genome editing reagents and viral vectors for the treatment of diseases, namely genetic diseases, diseases of the immune system, infectious diseases, autoimmune diseases, and cancer |
FILING BASIS | SECTION 1(b) |
INTERNATIONAL CLASS | 042 |
*IDENTIFICATION | Pharmaceutical research and development |
FILING BASIS | SECTION 1(b) |
ATTORNEY INFORMATION | |
NAME | Christopher K. Albert |
ATTORNEY DOCKET NUMBER | 5937.0009-00 |
ATTORNEY BAR MEMBERSHIP NUMBER | XXX |
YEAR OF ADMISSION | XXXX |
U.S. STATE/ COMMONWEALTH/ TERRITORY | XX |
FIRM NAME | Hamilton, Brook, Smith & Reynolds, P.C. |
STREET | 530 Virginia Road, P.O. Box 9133 |
CITY | Concord |
STATE | Massachusetts |
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | United States |
ZIP/POSTAL CODE | 01742-9133 |
PHONE | 978-341-0036 |
FAX | 978-341-0136 |
EMAIL ADDRESS | trademarks@hbsr.com |
OTHER APPOINTED ATTORNEY | David E. Brook, James M. Smith, John L. DuPré, Mary Lou Wakimura, Alice O. Carroll, Susan G. L. Glovsky, Timothy J. Meagher, Deirdre E. Sanders, Mark B. Solomon, Brian Moriarty, Lawrence P. Cogswell III, Eric M. Balicky, Alexander Adam, Rebecca L. Simmons |
CORRESPONDENCE INFORMATION | |
NAME | Christopher K. Albert |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE | trademarks@hbsr.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) | NOT PROVIDED |
FEE INFORMATION | |
APPLICATION FILING OPTION | TEAS Standard |
NUMBER OF CLASSES | 2 |
APPLICATION FOR REGISTRATION PER CLASS | 350 |
*TOTAL FEES DUE | 700 |
*TOTAL FEES PAID | 700 |
SIGNATURE INFORMATION | |
SIGNATURE | /Michael McDonald/ |
SIGNATORY'S NAME | Michael McDonald |
SIGNATORY'S POSITION | Authorized Signatory |
DATE SIGNED | 08/21/2021 |
SIGNATURE METHOD | Sent to third party for signature |
PTO- 1478 |
Approved for use through 08/31/2021. OMB 0651-0009 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Serial Number: 90895336 |
Filing Date: 08/21/2021 |
The applicant's current Correspondence Information: |
Christopher K. Albert |
PRIMARY EMAIL FOR CORRESPONDENCE: trademarks@hbsr.com SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): NOT PROVIDED Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS). |
|
|